// App-Quantinova.ai

T2038 2015 AHA : Relationships Between Mediterranea- and Wester- Dietary Patterns and Biomarkers Associated with Increased Cardiovascular Risk in Patients with Stable Coronary Heart Disease in the Global STABILITY Trial

Researchers

Presenter

  • Ralph A Stewart

Principal Investigators

  • Harvey D White

  • Jocelyne Benatar

  • Nicolas Danchin

  • Emil Hagström

  • Claes Held

  • Steen Husted

  • Eva Lonn

  • Nermin Hadziosmanovic

  • Ola Vedin

  • David Watson

  • Agneta Siegbahn

  • Lars Wallentin

Medical Centers

  • European Hosp Georges-Pompidiou, Paris, France

  • Uppsala University Hospital, Uppsala, Sweden

  • Hospital Unit West, Herning, Denmark

  • McMaster University, Hamilton, ON, Canada

  • Auckland City Hospital and University of Auckland, Auckland, New Zealand

Locations

  • Canada

  • France

  • Denmark

  • Sweden

  • New Zealand

Companies

  • GlaxoSmithKline plc.

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Hypertension

  • Tuberculosis

  • Diabetes

Biomarkers

  • Enzyme lipoprotein-associated phospholipase A2

  • Growth differentiation factor 15

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • ILS-969

  • CystC

  • Darapladib

  • lipase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved